Industry: Machinery & Equipment
Published Date: 2026-03-06
Pages: 142 Pages
Report ld: 6024088
Request Sample
Customized Report
Pharmaceutical Dry Granulator Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 167
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Dry Granulator market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 167 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Dry Granulator competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical Dry Granulators, also known as roll press granulators, are machines used in the dry granulation process to produce uniform, high-quality granules for the pharmaceutical industry. These machines apply pressure to the powder, compacting it into dense sheets, which are then broken down into granules. The process is particularly advantageous for heat-sensitive or moisture-sensitive materials, as it does not require the use of liquids or heat, making it suitable for certain types of pharmaceutical formulations.
The Pharmaceutical Dry Granulators market is a segment within the pharmaceutical manufacturing equipment industry focused on the production and sale of roller compactors, also known as roll press granulators. These machines are used to create granules from dry powder, which is a critical step in the manufacturing of solid oral dosage forms such as tablets and capsules. The market is driven by the increasing demand for high-quality pharmaceuticals, the shift toward more efficient and cost-effective manufacturing processes, and technological advancements in the field of dry granulation. The global pharmaceutical industry is expanding rapidly due to rising health concerns, the aging population, and increased access to healthcare services. This has led to a higher demand for pharmaceuticals, including generics and over-the-counter (OTC) drugs, which in turn drives the need for efficient manufacturing equipment like roller compactors. Roller compacting offers a significant advantage over wet granulation because it eliminates the need for liquid binders and drying processes. This results in reduced production time, energy consumption, and cost, making it an attractive solution for pharmaceutical manufacturers. The growing availability of generic drugs worldwide, particularly in markets like North America, Asia-Pacific, and Europe, is increasing the demand for efficient, cost-effective granulation equipment. Roller compactors are particularly suited for manufacturing high-dose generic formulations, which require high-quality granules for consistency. Increasing regulatory scrutiny, especially from agencies like the FDA and EMA, is pushing manufacturers to adopt more efficient and precise production processes. Roller compactors help in achieving uniform granule size distribution, which is crucial for ensuring consistent tablet weight, uniformity, and drug release characteristics.
This report delivers a comprehensive overview of the global Pharmaceutical Dry Granulator market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Dry Granulator. The Pharmaceutical Dry Granulator market size, estimates, and forecasts are provided in terms of output/shipments (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Dry Granulator market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Dry Granulator manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Dry Granulator manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Pharmaceutical Dry Granulator production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Pharmaceutical Dry Granulator consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharmaceutical Dry Granulator Market Overview
1.1 Product Definition
1.2 Pharmaceutical Dry Granulator by Type
1.2.1 Global Pharmaceutical Dry Granulator Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Below 30Kg/Hour
1.2.3 30-200Kg/Hour
1.2.4 Above 200Kg/Hour
1.3 Pharmaceutical Dry Granulator by Application
1.3.1 Global Pharmaceutical Dry Granulator Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Mid-size & Small Pharma Companies
1.3.3 Large Pharma Companies
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Dry Granulator Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Pharmaceutical Dry Granulator Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Pharmaceutical Dry Granulator Production Estimates and Forecasts (2021–2032)
1.4.4 Global Pharmaceutical Dry Granulator Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Dry Granulator Production Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Dry Granulator Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Pharmaceutical Dry Granulator, Industry Ranking, 2024 vs 2025
2.4 Global Pharmaceutical Dry Granulator Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Pharmaceutical Dry Granulator Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Pharmaceutical Dry Granulator, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Dry Granulator, Product Offerings and Applications
2.8 Global Key Manufacturers of Pharmaceutical Dry Granulator, Date of Entry into the Industry
2.9 Pharmaceutical Dry Granulator Market Competitive Situation and Trends
2.9.1 Pharmaceutical Dry Granulator Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Pharmaceutical Dry Granulator Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Pharmaceutical Dry Granulator Production by Region
3.1 Global Pharmaceutical Dry Granulator Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Dry Granulator Production Value by Region (2021–2032)
3.2.1 Global Pharmaceutical Dry Granulator Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Pharmaceutical Dry Granulator by Region (2027–2032)
3.3 Global Pharmaceutical Dry Granulator Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Pharmaceutical Dry Granulator Production Volume by Region (2021–2032)
3.4.1 Global Pharmaceutical Dry Granulator Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Pharmaceutical Dry Granulator by Region (2027–2032)
3.5 Global Pharmaceutical Dry Granulator Market Price Analysis by Region (2021–2032)
3.6 Global Pharmaceutical Dry Granulator Production, Value, and Year-over-Year Growth
3.6.1 North America Pharmaceutical Dry Granulator Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Pharmaceutical Dry Granulator Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Pharmaceutical Dry Granulator Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Pharmaceutical Dry Granulator Production Value Estimates and Forecasts (2021–2032)
4 Pharmaceutical Dry Granulator Consumption by Region
4.1 Global Pharmaceutical Dry Granulator Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Pharmaceutical Dry Granulator Consumption by Region (2021–2032)
4.2.1 Global Pharmaceutical Dry Granulator Consumption by Region (2021–2026)
4.2.2 Global Pharmaceutical Dry Granulator Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Pharmaceutical Dry Granulator Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Pharmaceutical Dry Granulator Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Dry Granulator Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Pharmaceutical Dry Granulator Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Dry Granulator Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Pharmaceutical Dry Granulator Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Dry Granulator Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Pharmaceutical Dry Granulator Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Dry Granulator Production by Type (2021–2032)
5.1.1 Global Pharmaceutical Dry Granulator Production by Type (2021–2026)
5.1.2 Global Pharmaceutical Dry Granulator Production by Type (2027–2032)
5.1.3 Global Pharmaceutical Dry Granulator Production Market Share by Type (2021–2032)
5.2 Global Pharmaceutical Dry Granulator Production Value by Type (2021–2032)
5.2.1 Global Pharmaceutical Dry Granulator Production Value by Type (2021–2026)
5.2.2 Global Pharmaceutical Dry Granulator Production Value by Type (2027–2032)
5.2.3 Global Pharmaceutical Dry Granulator Production Value Market Share by Type (2021–2032)
5.3 Global Pharmaceutical Dry Granulator Price by Type (2021–2032)
6 Segment by Application
6.1 Global Pharmaceutical Dry Granulator Production by Application (2021–2032)
6.1.1 Global Pharmaceutical Dry Granulator Production by Application (2021–2026)
6.1.2 Global Pharmaceutical Dry Granulator Production by Application (2027–2032)
6.1.3 Global Pharmaceutical Dry Granulator Production Market Share by Application (2021–2032)
6.2 Global Pharmaceutical Dry Granulator Production Value by Application (2021–2032)
6.2.1 Global Pharmaceutical Dry Granulator Production Value by Application (2021–2026)
6.2.2 Global Pharmaceutical Dry Granulator Production Value by Application (2027–2032)
6.2.3 Global Pharmaceutical Dry Granulator Production Value Market Share by Application (2021–2032)
6.3 Global Pharmaceutical Dry Granulator Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Fitzpatrick
7.1.1 Fitzpatrick Pharmaceutical Dry Granulator Company Information
7.1.2 Fitzpatrick Pharmaceutical Dry Granulator Product Portfolio
7.1.3 Fitzpatrick Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Fitzpatrick Main Business and Markets Served
7.1.5 Fitzpatrick Recent Developments/Updates
7.2 Hosokawa
7.2.1 Hosokawa Pharmaceutical Dry Granulator Company Information
7.2.2 Hosokawa Pharmaceutical Dry Granulator Product Portfolio
7.2.3 Hosokawa Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Hosokawa Main Business and Markets Served
7.2.5 Hosokawa Recent Developments/Updates
7.3 Alexanderwerk
7.3.1 Alexanderwerk Pharmaceutical Dry Granulator Company Information
7.3.2 Alexanderwerk Pharmaceutical Dry Granulator Product Portfolio
7.3.3 Alexanderwerk Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Alexanderwerk Main Business and Markets Served
7.3.5 Alexanderwerk Recent Developments/Updates
7.4 Freund Corporation
7.4.1 Freund Corporation Pharmaceutical Dry Granulator Company Information
7.4.2 Freund Corporation Pharmaceutical Dry Granulator Product Portfolio
7.4.3 Freund Corporation Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Freund Corporation Main Business and Markets Served
7.4.5 Freund Corporation Recent Developments/Updates
7.5 Beijing LongliTech
7.5.1 Beijing LongliTech Pharmaceutical Dry Granulator Company Information
7.5.2 Beijing LongliTech Pharmaceutical Dry Granulator Product Portfolio
7.5.3 Beijing LongliTech Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Beijing LongliTech Main Business and Markets Served
7.5.5 Beijing LongliTech Recent Developments/Updates
7.6 GERTEIS
7.6.1 GERTEIS Pharmaceutical Dry Granulator Company Information
7.6.2 GERTEIS Pharmaceutical Dry Granulator Product Portfolio
7.6.3 GERTEIS Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 GERTEIS Main Business and Markets Served
7.6.5 GERTEIS Recent Developments/Updates
7.7 L.B. Bohle
7.7.1 L.B. Bohle Pharmaceutical Dry Granulator Company Information
7.7.2 L.B. Bohle Pharmaceutical Dry Granulator Product Portfolio
7.7.3 L.B. Bohle Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 L.B. Bohle Main Business and Markets Served
7.7.5 L.B. Bohle Recent Developments/Updates
7.8 Yenchen Machinery
7.8.1 Yenchen Machinery Pharmaceutical Dry Granulator Company Information
7.8.2 Yenchen Machinery Pharmaceutical Dry Granulator Product Portfolio
7.8.3 Yenchen Machinery Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Yenchen Machinery Main Business and Markets Served
7.8.5 Yenchen Machinery Recent Developments/Updates
7.9 WelchDry
7.9.1 WelchDry Pharmaceutical Dry Granulator Company Information
7.9.2 WelchDry Pharmaceutical Dry Granulator Product Portfolio
7.9.3 WelchDry Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 WelchDry Main Business and Markets Served
7.9.5 WelchDry Recent Developments/Updates
7.10 Cadmach
7.10.1 Cadmach Pharmaceutical Dry Granulator Company Information
7.10.2 Cadmach Pharmaceutical Dry Granulator Product Portfolio
7.10.3 Cadmach Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Cadmach Main Business and Markets Served
7.10.5 Cadmach Recent Developments/Updates
7.11 Canaan Technology
7.11.1 Canaan Technology Pharmaceutical Dry Granulator Company Information
7.11.2 Canaan Technology Pharmaceutical Dry Granulator Product Portfolio
7.11.3 Canaan Technology Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Canaan Technology Main Business and Markets Served
7.11.5 Canaan Technology Recent Developments/Updates
7.12 Bepex
7.12.1 Bepex Pharmaceutical Dry Granulator Company Information
7.12.2 Bepex Pharmaceutical Dry Granulator Product Portfolio
7.12.3 Bepex Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Bepex Main Business and Markets Served
7.12.5 Bepex Recent Developments/Updates
7.13 Prism Pharma Machinery
7.13.1 Prism Pharma Machinery Pharmaceutical Dry Granulator Company Information
7.13.2 Prism Pharma Machinery Pharmaceutical Dry Granulator Product Portfolio
7.13.3 Prism Pharma Machinery Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Prism Pharma Machinery Main Business and Markets Served
7.13.5 Prism Pharma Machinery Recent Developments/Updates
7.14 KEYUAN
7.14.1 KEYUAN Pharmaceutical Dry Granulator Company Information
7.14.2 KEYUAN Pharmaceutical Dry Granulator Product Portfolio
7.14.3 KEYUAN Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 KEYUAN Main Business and Markets Served
7.14.5 KEYUAN Recent Developments/Updates
7.15 KaiChuang Machinery
7.15.1 KaiChuang Machinery Pharmaceutical Dry Granulator Company Information
7.15.2 KaiChuang Machinery Pharmaceutical Dry Granulator Product Portfolio
7.15.3 KaiChuang Machinery Pharmaceutical Dry Granulator Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 KaiChuang Machinery Main Business and Markets Served
7.15.5 KaiChuang Machinery Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Dry Granulator Industry Chain Analysis
8.2 Pharmaceutical Dry Granulator Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Dry Granulator Production Modes and Processes
8.4 Pharmaceutical Dry Granulator Sales and Marketing
8.4.1 Pharmaceutical Dry Granulator Sales Channels
8.4.2 Pharmaceutical Dry Granulator Distributors
8.5 Pharmaceutical Dry Granulator Customer Analysis
9 Pharmaceutical Dry Granulator Market Dynamics
9.1 Pharmaceutical Dry Granulator Industry Trends
9.2 Pharmaceutical Dry Granulator Market Drivers
9.3 Pharmaceutical Dry Granulator Market Challenges
9.4 Pharmaceutical Dry Granulator Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 91
USD 4250.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 167 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 111
USD 3950.00
(Single User License)
The global Pharmaceutical Dry Granulator market is projected to grow from US$ 105 million in 2024 to US$ 159 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 170
USD 4900.00
(Single User License)
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-02-09
Pages: 119
USD 3950.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-02-09
Pages: 105
USD 2900.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 148
USD 3950.00
(Single User License)
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-04-12
Pages: 115
USD 4900.00
(Single User License)
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 110
USD 2900.00
(Single User License)
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-01-08
Pages: 140
USD 3950.00
(Single User License)
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 91
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 167 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 111
The global Pharmaceutical Dry Granulator market is projected to grow from US$ 105 million in 2024 to US$ 159 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 170
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 119
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-02-09
Pages: 105
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 148
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-04-12
Pages: 115
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 110
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-01-08
Pages: 140
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now